Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;89(12):1643-5.
doi: 10.1136/bjo.2005.075978.

Expression of FGFR-2 and FGFR-3 in the normal human fetal orbit

Affiliations

Expression of FGFR-2 and FGFR-3 in the normal human fetal orbit

S H Khan et al. Br J Ophthalmol. 2005 Dec.

Abstract

Aims: To demonstrate the expression patterns of two fibroblast growth factor receptors (FGFR-2 and FGFR-3) in the normal human fetal orbit.

Methods: 6 microm orbital slide sections were prepared from 12 week old human fetal material obtained within established ethical guidelines. Radioactive in situ hybridisation techniques were used to demonstrate the expression patterns of FGFR-2 and FGFR-3 within these sections. Only one foetus had appropriate orbital sections taken.

Results: FGFR-2 was expressed within the extraocular muscles (EOMs) and the optic nerve sheath and to a lesser degree within the orbital periosteal margins and the cranial sutures. FGFR-3 was expressed a lot within the periosteal margins and cranial sutures but not within either the EOMs or the optic nerve sheath.

Conclusions: FGFR-2 and FGFR-3 are differentially expressed within different orbital components. FGFR-2 gene mutations may be responsible for craniosynostotic syndromes such as Crouzon, Pfeiffer, and Apert, while those in the FGFR-3 gene may cause isolated unicoronal synostosis. EOMs may be histologically abnormal in cases of Apert, Pfeiffer, and Crouzon syndromes but not isolated unicoronal synostosis. The pattern of expression of FGFR-2 in the normal human fetal orbit may explain some of the EOM histological findings seen in some cases of Apert, Pfeiffer, and Crouzon syndromes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of FGFR2—dark brown indicates positive stain (arrows)—predominantly within muscles and optic nerve sheath. LR, lateral rectus; SR, superior rectus; MR, medial rectus; SO, superior oblique; ON, optic nerve.
Figure 2
Figure 2
Expression of FGFR3—dark brown indicates positive stain (arrows)—periosteal margins and sutures but not in muscle or optic nerve sheath. LR, lateral rectus; SR, superior rectus; MR, medial rectus; SO, superior oblique; ON, optic nerve.

Similar articles

Cited by

References

    1. Khan SH, Nischal KK, Dean F, et al. Visual outcomes and amblyogenic risk factors in the syndromic craniosynostoses—a review of 141 cases. Br J Ophthalmol 2003;87:999–1003. - PMC - PubMed
    1. Vajo Z, Francomano CA, Wilkin D. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocrine Rev 2000;21:23–39. - PubMed
    1. De Moerlooze L, Dickson C. Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr Opin Genet Develop 1997;7:378–85. - PubMed
    1. Cheng H, et al. Dissociated eye movements in craniosynostosis: a hypothesis revived. Br J Ophthalmol 1993;77:563–8. - PMC - PubMed
    1. Captuo A, Lingua R. Abberrant muscle insertions in Crouzon’s disease. J Pediatr Ophthalmol Strabismus 1980;17:239–41. - PubMed

MeSH terms

Substances